Top

Published in:

01-06-2018 | What's New in Intensive Care

What’s new in prognostication after cardiac arrest: microRNAs?

Authors: Yvan Devaux, Pascal Stammet, On behalf of the Cardiolinc™ network

Published in: Intensive Care Medicine | Issue 6/2018

Excerpt

Predicting whether a patient in an intensive care unit after a cardiac arrest (CA) will recover in good condition or will suffer irreversible and severe neurologic damage is challenging. Such prognostication would allow adapting healthcare to each individual, reduce the economic burden on the society, and inform patient relatives about the most plausible outcome at an early stage. It may also eventually serve as a solid basis for withdrawal of life-supporting therapies in futile cases. Current guidelines recommend the use of multimodal strategies for prediction of outcome. Yet, the risk of inaccurate prediction still remains, and complementary modalities may help to improve prediction accuracy. …

Adielsson A, Hollenberg J, Karlsson T, Lindqvist J, Lundin S, Silfverstolpe J, Svensson L, Herlitz J (2011) Increase in survival and bystander CPR in out-of-hospital shockable arrhythmia: bystander CPR and female gender are predictors of improved outcome. Experiences from Sweden in an 18-year perspective. Heart 97:1391–1396CrossRefPubMed

Wissenberg M, Lippert FK, Folke F, Weeke P, Hansen CM, Christensen EF, Jans H, Hansen PA, Lang-Jensen T, Olesen JB, Lindhardsen J, Fosbol EL, Nielsen SL, Gislason GH, Kober L, Torp-Pedersen C (2013) Association of national initiatives to improve cardiac arrest management with rates of bystander intervention and patient survival after out-of-hospital cardiac arrest. JAMA 310:1377–1384CrossRefPubMed

Sunde K, Pytte M, Jacobsen D, Mangschau A, Jensen LP, Smedsrud C, Draegni T, Steen PA (2007) Implementation of a standardised treatment protocol for post resuscitation care after out-of-hospital cardiac arrest. Resuscitation 73:29–39CrossRefPubMed

Nielsen N, Wetterslev J, Cronberg T, Erlinge D, Gasche Y, Hassager C, Horn J, Hovdenes J, Kjaergaard J, Kuiper M, Pellis T, Stammet P, Wanscher M, Wise MP, Aneman A, Al-Subaie N, Boesgaard S, Bro-Jeppesen J, Brunetti I, Bugge JF, Hingston CD, Juffermans NP, Koopmans M, Kober L, Langorgen J, Lilja G, Moller JE, Rundgren M, Rylander C, Smid O, Werer C, Winkel P, Friberg H, Investigators TTMT (2013) Targeted temperature management at 33 °C versus 36 °C after cardiac arrest. N Engl J Med 369:2197–2206CrossRefPubMed

Kirkegaard H, Soreide E, de Haas I, Pettila V, Taccone FS, Arus U, Storm C, Hassager C, Nielsen JF, Sorensen CA, Ilkjaer S, Jeppesen AN, Grejs AM, Duez CHV, Hjort J, Larsen AI, Toome V, Tiainen M, Hastbacka J, Laitio T, Skrifvars MB (2017) Targeted temperature management for 48 vs 24 hours and neurologic outcome after out-of-hospital cardiac arrest: a randomized clinical trial. JAMA 318:341–350CrossRefPubMedPubMedCentral

Nolan JP, Soar J, Cariou A, Cronberg T, Moulaert VR, Deakin C, Bottiger B, Friberg H, Sunde K, Sandroni C (2015) European resuscitation council guidelines for resuscitation 2015 section 5. Post resuscitation care. Resuscitation 95:202–222

Stammet P, Collignon O, Hassager C, Wise MP, Hovdenes J, Åneman A, Horn J, Devaux Y, Erlinge D, Kjaergaard J, Gasche Y, Wanscher M, Cronberg T, Friberg H, Wetterslev J, Pellis T, Kuiper M, Gilson G, Nielsen N (2015) Neuron-specific enolase as a predictor of death or poor neurological outcome after out-of-hospital cardiac arrest and targeted temperature management at 33 °C and 36 °C. J Am Coll Cardiol 65:2104–2114CrossRefPubMed

Stammet P, Dankiewicz J, Nielsen N, Fays F, Collignon O, Hassager C, Wanscher M, Unden J, Wetterslev J, Pellis T, Aneman A, Hovdenes J, Wise MP, Gilson G, Erlinge D, Horn J, Cronberg T, Kuiper M, Kjaergaard J, Gasche Y, Devaux Y, Friberg H, Target Temperature Management after Out-of-Hospital Cardiac Arrest trial i (2017) Protein S100 as outcome predictor after out-of-hospital cardiac arrest and targeted temperature management at 33 °C and 36 °C. Crit Care 21:153CrossRefPubMedPubMedCentral

Rink C, Khanna S (2011) MicroRNA in ischemic stroke etiology and pathology. Physiol Genom 43:521–528CrossRef

10.

Stammet P, Goretti E, Vausort M, Zhang L, Wagner DR, Devaux Y (2012) Circulating microRNAs after cardiac arrest. Crit Care Med 40:3209–3214CrossRefPubMed

11.

Gilje P, Gidlof O, Rundgren M, Cronberg T, Al-Mashat M, Olde B, Friberg H, Erlinge D (2014) The brain-enriched microRNA miR-124 in plasma predicts neurological outcome after cardiac arrest. Crit Care 18:R40CrossRefPubMedPubMedCentral

12.

Devaux Y, Dankiewicz J, Salgado-Somoza A, Stammet P, Collignon O, Gilje P, Gidlof O, Zhang L, Vausort M, Hassager C, Wise MP, Kuiper M, Friberg H, Cronberg T, Erlinge D, Nielsen N, For Target Temperature Management After Cardiac Arrest Trial I (2016) Association of circulating microRNA-124-3p levels with outcomes after out-of-hospital cardiac arrest: a substudy of a randomized clinical trial. JAMA Cardiol 1:305–313CrossRefPubMed

13.

Devaux Y, Salgado-Somoza A, Dankiewicz J, Boileau A, Stammet P, Schritz A, Zhang L, Vausort M, Gilje P, Erlinge D, Hassager C, Wise MP, Kuiper M, Friberg H, Nielsen N, Investigators TT-t (2017) Incremental value of circulating MiR-122-5p to predict outcome after out of hospital cardiac arrest. Theranostics 7:2555–2564CrossRefPubMedPubMedCentral

14.

Lei P, Li Y, Chen X, Yang S, Zhang J (2009) Microarray based analysis of microRNA expression in rat cerebral cortex after traumatic brain injury. Brain Res 1284:191–201CrossRefPubMed

15.

Andersson P, Gidlof O, Braun OO, Gotberg M, van der Pals J, Olde B, Erlinge D (2012) Plasma levels of liver-specific miR-122 is massively increased in a porcine cardiogenic shock model and attenuated by hypothermia. Shock 37:234–238CrossRefPubMed

16.

Laterza OF, Lim L, Garrett-Engele PW, Vlasakova K, Muniappa N, Tanaka WK, Johnson JM, Sina JF, Fare TL, Sistare FD, Glaab WE (2009) Plasma MicroRNAs as sensitive and specific biomarkers of tissue injury. Clin Chem 55:1977–1983CrossRefPubMed

Title: What’s new in prognostication after cardiac arrest: microRNAs?
Authors: Yvan Devaux
Pascal Stammet
On behalf of the Cardiolinc™ network
Publication date: 01-06-2018
Publisher: Springer Berlin Heidelberg
Published in: Intensive Care Medicine / Issue 6/2018
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI: https://doi.org/10.1007/s00134-017-4995-6

At a glance: The STEP trials

Springer Medicine

What’s new in prognostication after cardiac arrest: microRNAs?

Excerpt

At a glance: The STEP trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 6/2018

Transthoracic cardiac ultrasound in prone position: a technique variation description

A state of the art review on optimal practices to prevent, recognize, and manage complications associated with intravascular devices in the critically ill

Epinephrine and short-term survival in cardiogenic shock: an individual data meta-analysis of 2583 patients

The ten things you need to know about long-term outcomes following paediatric cardiac surgery

Expert statement for the management of hypovolemia in sepsis

A global perspective on vasoactive agents in shock